Discontinued — last reported Q4 '20
Investing
Business Sale Proceeds
UnitedHealth Group Business Sale Proceeds increased by 5047.6% to $1.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5047.6%, from $21.00M to $1.08B. Over 3 years (FY 2021 to FY 2024), Business Sale Proceeds shows an upward trend with a 414.3% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2020
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.75M | $3.75M | $3.75M | $853.50M | $853.50M | $853.50M | $853.50M | $171.25M | $171.25M | $171.25M | $171.25M | $510.25M | $510.25M | $510.25M | $510.25M | $21.00M | $1.08B |
| QoQ Change | — | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -79.9% | +0.0% | +0.0% | +0.0% | +198.0% | +0.0% | +0.0% | +0.0% | -95.9% | >999% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -79.9% | -79.9% | -79.9% | -79.9% | +198.0% | +198.0% | +198.0% | +198.0% | -95.9% | >999% |
Range$3.75M – $1.08B
CAGR+312.0%
Avg YoY Growth>999%
Median YoY Growth+198.0%
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's business sale proceeds?
- UnitedHealth Group (UNH) reported business sale proceeds of $1.08B in Q1 2026.
- How has UnitedHealth Group's business sale proceeds changed year-over-year?
- UnitedHealth Group's business sale proceeds increased by 5047.6% year-over-year, from $21.00M to $1.08B.
- What is the long-term trend for UnitedHealth Group's business sale proceeds?
- Over 3 years (2021 to 2024), UnitedHealth Group's business sale proceeds has grown at a 414.3% compound annual growth rate (CAGR), from $15.00M to $2.04B.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.